Ernexa Therapeutics, Inc. (ERNA)
1.31
+0.16
(+13.91%)
USD |
NASDAQ |
Dec 04, 16:00
1.29
-0.02
(-1.53%)
After-Hours: 20:00
Ernexa Therapeutics EPS Diluted (Quarterly): -0.1507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.24M |
| Total Expenses (Quarterly) | 1.24M |
| Enterprise Value | 7.149M |
| Earnings Yield | -198.1% |
| Normalized Earnings Yield | -194.03 |